[Form 4] Cognizant Technology Solutions Insider Trading Activity

Rhea-AI Filing Summary

Alina Kerdman, SVP, Controller & CAO of Cognizant Technology Solutions Corp (CTSH), reported a sale of Class A common stock. The Form 4 discloses a sale of 439 shares on 08/19/2025 at a price of $70.38 per share, leaving the reporting person with 160 shares beneficially owned following the transaction. The filing was submitted on behalf of Ms. Kerdman by power of attorney and signed on 08/21/2025.

Positive

• Transparency: The officer timely reported the transaction on Form 4 and used a power of attorney signature, showing compliance with reporting rules
• No derivatives: The filing shows only a straight sale of common stock with no option exercises or derivative transactions disclosed

Negative

• Insider sale: An executive sold shares (439 at $70.38), which some investors may interpret as insider liquidity rather than confidence-related buying

Insights

Corporate Governance Expert

TL;DR: An officer sale of a modest number of shares; routine insider liquidity rather than a governance red flag.

This Form 4 records an open-market sale by a senior finance officer, which is common for personal liquidity or portfolio rebalancing. The transaction size (439 shares) and remaining ownership (160 shares) are small relative to typical executive holdings and do not by themselves indicate changes in control or firm governance. No additional derivative transactions or plans (e.g., 10b5-1) are disclosed in this filing.

Securities Analyst

TL;DR: Small-scale insider sale with limited market or valuation impact.

The sale executed at $70.38 per share for 439 shares represents a modest insider disposition. There are no accompanying derivative exercises or large-scale disposals reported here. Because the number of shares and residual ownership are limited, this filing is unlikely to be material to investors assessing company fundamentals or near-term valuation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kerdman Alina

(Last) (First) (Middle)

C/O COGNIZANT TECHNOLOGY SOLUTIONS CORP.

300 FRANK W. BURR BLVD., STE 36, 6 FL.

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNIZANT TECHNOLOGY SOLUTIONS CORP [ CTSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Controller & CAO

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/19/2025		S		439	D	$70.38	160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kelli Arman, on behalf of Alina Kerdman, by Power of Attorney	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for CTSH filed by Alina Kerdman disclose?

The filing disclosed a sale of 439 shares of Class A common stock on 08/19/2025 at $70.38 per share, leaving 160 shares beneficially owned.

What is Alina Kerdman's role at Cognizant (CTSH)?

The Form 4 lists her relationship to the issuer as SVP, Controller & CAO.

Was the Form 4 signed by Alina Kerdman?

The form was signed on behalf of Alina Kerdman by Kelli Arman under power of attorney and dated 08/21/2025.

Does the filing show any derivative or option transactions for CTSH by this reporting person?

No. Table II (derivative securities) contains no reported transactions; only a non-derivative sale is shown.

How many shares did the reporting person own after the transaction?

The Form 4 reports 160 shares beneficially owned following the reported sale.